Showing results (371-380 of 516) with videos related to
Sort By:
Pageof 52
Journal of Neuro-Oncology|March 6, 2013
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour studyDarren Hargrave, Birgit Geoerger, Didier Frappaz, et al.Neurology|February 27, 2015
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphomaAgnieszka Korfel, Eckhard Thiel, Peter Martus, et al.Journal of Neuro-Oncology|October 17, 2021
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studiesJonas E Adolph, Gudrun Fleischhack, Christine Gaab, et al.Acta Neuropathologica|January 6, 2024
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytomaMichael Weller, Jörg Felsberg, Bettina Hentschel, et al.European Journal of Cancer (Oxford, England : 1990)|July 30, 2020
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomasEnrico Franceschi, Alicia Tosoni, Stefania Bartolini, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2021
Inclusion of Synovial Tissue-Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment-Naive Rheumatoid Arthritis PatientsStefano Alivernini, Barbara Tolusso, Marco Gessi, et al.Cancer Research Communications|April 23, 2024
The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with GlioblastomaCarolina Giordano, Laura Marrone, Simona Romano, et al.BMC Cancer|September 4, 2009
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II studyChristoph P Beier, Christina Schmid, Thierry Gorlia, et al.Plos One|September 5, 2008
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological featuresMarcel Kool, Jan Koster, Jens Bunt, et al.Clinical Epigenetics|June 27, 2020
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanomaFriederike Hoffmann, Romina Zarbl, Dennis Niebel, et al.Pageof 52